Literature DB >> 11323161

Up-regulation of transporters of the MRP family by drugs and toxins.

D Schrenk1, P R Baus, N Ermel, C Klein, B Vorderstemann, H M Kauffmann.   

Abstract

Expression of a variety of ABC efflux pumps including certain conjugate transporters of the multidrug resistance protein (MRP) subfamily is inducible in primate and rodent tissues, and in a variety of cell lines and primary cells in culture. In human cell lines (HepG2, MCF-7), we studied the inducibility of MRPs 1-5. Similar to the rat mrp2 gene, human mrp2 is inducible by the chemical carcinogen 2-AAF, the chemotherapeutic drug cisplatin and the barbiturate phenobarbital, as demonstrated in Northern and Western Blots. Furthermore, the antibiotic rifampicin was identified as MRP2 inducer in HepG2 cells. MRP1 and 4 mRNAs being expressed in human liver at a very low level could not be detected in HepG2 cells after treatment with various agents. However, MRP3 and 5 mRNAs were detected in addition to MRP2 and their expression was found to be increased by 2-AAF, cisplatin and rifampicin. MRP1 expression was studied in MCF-7 cells where the chemotherapeutic drug vinblastine and tert-butyl hydroquinone but not the MRP2 inducing agents described above acted as inducers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323161     DOI: 10.1016/s0378-4274(01)00306-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  29 in total

1.  Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.

Authors:  Xiaoli Zhang; Bin Xu; Chuanying Sun; Liming Wang; Xia Miao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Transporters in the intestine limiting drug and toxin absorption.

Authors:  R P J Oude Elferink; R de Waart
Journal:  J Physiol Biochem       Date:  2007-03       Impact factor: 4.158

Review 3.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

Review 5.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.

Authors:  Yang Shen; Mulan Ren; Yuehua Shi; Yunxia Zhang; Yunlang Cai
Journal:  Exp Ther Med       Date:  2011-08-11       Impact factor: 2.447

7.  Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.

Authors:  Ying-hui Chen; Cui-cui Wang; Xia Xiao; Li Wei; Guoxiong Xu
Journal:  Acta Pharmacol Sin       Date:  2013-03-11       Impact factor: 6.150

8.  Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis.

Authors:  J Wolf; T Stranzl; M Filipits; G Pohl; R Pirker; B Leeb; J S Smolen
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

9.  Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.

Authors:  P Martin; R Riley; D J Back; A Owen
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 10.  ABC of oral bioavailability: transporters as gatekeepers in the gut.

Authors:  C G Dietrich; A Geier; R P J Oude Elferink
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.